We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Milestone Achieved in the Regeneration of Brain Cells

By Biotechdaily staff writers
Posted on 04 Sep 2007
A research group has achieved an additional step for the potential replacement of damaged brain cells after injury or disease: functional nerve cells can be generated from astroglia, a type of supportive cells in the brain by means of dedicated regulator proteins.

The majority of cells in the human brain are not nerve cells but star-shaped glia cells, the so-called astroglia, according to the researchers, from the Institute of Stem Cell Research of the GSF-National Research Center for Environment and Health (Neuherberg, Germany), and the Ludwig Maximilians University (Munich, Germany). More...
"Glia means glue,” explained Prof. Dr. Magdalena Götz, from GSF-National Research Center for Environment and Health. "As befits their name, until now these cells have been regarded merely as a kind of ‘putty' keeping the nerve cells together.”

A couple of years ago, the researchers were able to confirm that these glia cells function as stem cells during development. This means that they are able to differentiate into functional nerve cells. However, this ability gets lost in later stages of development, so that even after an injury to the adult brain, glial cells are unable to generate any more nerve cells.

To be able to reverse this development, the team evaluated what molecular switches are needed for the creation of nerve cells from glial cells during development. These regulator proteins are introduced into glial cells from the postnatal brain, which then respond by triggering the expression of neuronal proteins.

In his current study, Dr. Benedikt Berninger, from the Ludwig Maximilians University, was able to demonstrate that single regulator proteins were quite sufficient to generate new functional nerve cells from glia cells. The transition from glia-to-neuron could be tracked live with a time-lapse microscope. It was shown that glia cells needed time for the reprogramming until they take the normal shape of a nerve cell. "These new nerve cells then have also the typical electrical properties of normal nerve cells,” emphasized Dr. Berninger. "We could show this by means of electrical recordings.”

"Our results are very encouraging, because the generation of correctly functional nerve cells from postnatal glia cells is an important step on the way to be able to replace functional nerve cells also after injuries in the brain,” stressed Dr. Götz.

The researchers published their findings in the August 8, 2007, issue of the Journal of Neuroscience.


Related Links:
Institute of Stem Cell Research of the GSF-National Research Center for Environment and Health
Ludwig Maximilians University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

UK Project Advances Blood-Based Dementia Testing Toward Routine Clinical Care

Dementia is the leading cause of death in the UK, accounting for almost one in eight deaths, with more than 72,000 people dying from dementia, including Alzheimer’s disease, in 2025. Despite this burden,... Read more

Microbiology

view channel
Image: Overview of a rapid diagnostic workflow for fungal bloodstream infections (Photo courtesy of Professor Hiroki Takahashi and IMO, Chiba University, Japan)

Genomic Workflow Identifies Fungal Pathogens Before Blood Cultures Turn Positive

Fungal bloodstream infections pose a major threat to hospitalized patients. Candida species cause most invasive fungal infections worldwide and are among the leading causes of hospital-acquired bloodstream... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.